Prosecution Insights
Last updated: April 19, 2026

Shanghai Institute Of Materia Medica Chinese Academy Of Sciences

6 pending office actions

Portfolio Summary

6
Total Pending OAs
1
Final Rejections
5
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18286416 NUCLEOSIDE ANALOG AND USE THEREOF MILLER, DALE R 1693 Non-Final OA Oct 11, 2023
18278063 S-CONFIGURATION-CONTAINING AMINO BENZAMIDE PYRIDAZINONE COMPOUND, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF SHIAO, REI TSANG 1691 Non-Final OA Aug 21, 2023
18013696 OXADIAZOLE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF O DELL, DAVID K 1621 Non-Final OA Aug 10, 2023
18267298 THYROID HORMONE RECEPTOR b SELECTIVE AGONIST COMPOUND, PHARMACEUTICAL COMPOSITION AND USE THEREOF ROBINSON, MIKHAIL O'DONNEL 1627 Final Rejection Jun 14, 2023
18014932 PENTACYCLIC TRITERPENOID GLYCOSIDE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF ROZOF, TIMOTHY R 1625 Non-Final OA Jan 06, 2023
17765354 DRUG FOR TREATING ARTERY-RELATED DISEASES, AND USE THEREOF HUTTER, GILLIAN A 1625 Non-Final OA Mar 30, 2022

Managing Shanghai Institute Of Materia Medica Chinese Academy Of Sciences's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month